MARAVAI LIFESCIENCES HLDGS I's ticker is MRVI and the CUSIP is 56600D107. A total of 234 filers reported holding MARAVAI LIFESCIENCES HLDGS I in Q1 2022. The put-call ratio across all filers is 0.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,774,870 | -31.6% | 577,487 | -15.0% | 0.01% | -36.8% |
| Q2 2023 | $8,442,493 | -66.8% | 679,203 | -61.8% | 0.02% | -72.9% |
| Q4 2022 | $25,421,873 | -16.5% | 1,776,511 | +49.0% | 0.07% | -24.7% |
| Q3 2022 | $30,448,000 | +93.2% | 1,192,661 | +115.0% | 0.09% | +82.4% |
| Q2 2022 | $15,758,000 | +31.1% | 554,687 | +62.7% | 0.05% | +34.2% |
| Q1 2022 | $12,024,000 | +2769.7% | 340,895 | +3309.0% | 0.04% | +3700.0% |
| Q4 2021 | $419,000 | -97.5% | 10,000 | -97.9% | 0.00% | -98.8% |
| Q1 2021 | $16,592,000 | -40.8% | 465,542 | -53.4% | 0.08% | -47.4% |
| Q4 2020 | $28,013,000 | – | 998,671 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GTCR LLC | 21,681,033 | $1,064,105,000 | 26.99% |
| Ghisallo Capital Management LLC | 1,250,000 | $61,350,000 | 2.33% |
| Beck Bode, LLC | 160,064 | $7,856,000 | 2.19% |
| Select Equity Group, L.P. | 12,122,011 | $594,948,300,000 | 2.00% |
| Pinz Capital Management, LP | 83,603 | $4,103,000 | 1.86% |
| Monashee Investment Management LLC | 185,000 | $9,080,000 | 1.68% |
| Ownership Capital B.V. | 2,717,559 | $133,378,000 | 1.51% |
| Eversept Partners, LP | 327,810 | $16,088,915 | 1.12% |
| Parkman Healthcare Partners LLC | 90,000 | $4,417,000 | 1.12% |
| Connacht Asset Management LP | 28,569 | $1,402,000 | 0.91% |